Elanco Animal Health Incorporat (ELAN) Financials
ELAN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 14.4 billion | 8.1 billion |
2023-09-30 | 14.3 billion | 8.2 billion |
2023-06-30 | 15.8 billion | 8.4 billion |
2023-03-31 | 15.8 billion | 8.3 billion |
ELAN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 116.0 million | 15.0 million |
2023-09-30 | 165.0 million | 10.0 million |
2023-06-30 | 19.0 million | 9.0 million |
2023-03-31 | -183.0 million | 12.0 million |
ELAN Net Income
No data available :(
ELAN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 352.0 million | - | - |
2023-09-30 | 369.0 million | - | - |
2023-06-30 | 367.0 million | - | - |
2023-03-31 | 318.0 million | - | - |
ELAN Shares Outstanding
ELAN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 41.0 million | 79.0 million | 292.0 million | - |
2023-09-30 | 33.0 million | 86.0 million | 313.0 million | - |
2023-06-30 | 42.0 million | 81.0 million | 353.0 million | - |
2023-03-31 | 38.0 million | 81.0 million | 327.0 million | - |
ELAN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 1.0 billion | 516.0 million |
2023-09-30 | 1.1 billion | 487.0 million |
2023-06-30 | 1.1 billion | 434.0 million |
2023-03-31 | 1.3 billion | 494.0 million |
ELAN
Price: $13.53
52 week price:
Earnings Per Share: -2.50 USD
P/E Ratio: -6.90
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 5.1 million
Market Capitalization: 7.7 billion